CONFIRMING FALSE HOMOZYGOSITY INPRE-TRANSPLANT HLA TESTING
Keywords:
Loss of heterozygosity (LOH), HLA genotyping, Chromosome 6p, Copy-neutral LOH, Acute myeloid leukemia (AML), Hematopoietic stem cell transplantation, Chromosomal microarray analysis (CMA), False homozygosity, Buccal swab typing, Blast crisisAbstract
The HLA gene complex is located on chromosome 6p, and this article examines a patient with acute myeloid leukemia (AML) who has the incorrect HLA homozygosity due to loss of heterozygosity (LOH). Successful hematopoietic stem cell transplant matching relies on precise HLA compatibility testing. Confusion in clinical conditions could arise if LOH is not detected. Oral swabs and peripheral blood samples were used for HLA molecular typing using methodologies such as sequence-based approaches, next-generation sequencing technologies, and chromosomal microarray analysis (CMA). After a bone marrow exam, it was determined that a 68-year-old man suffering from low platelets and anemia had acute myeloid leukemia (AML). Although the karyotype was normal, the blast crisis HLA testing of peripheral blood revealed that all three HLA loci—A, -B, and -C—were likely homozygous (46, XY[20]). Additional testing confirmed the previous results. Heterozygosity at each locus was determined by HLA typing using DNA from oral swabs. Afterwards, a substantial copy-neutral LOH region spanning from 6p25.3 to 6p21.1 and measuring approximately 43.5 Mb in length was discovered by CMA. By providing a reason for the divergent outcomes, this demonstrated the significance of checking for unexpected homozygosity in non-hematopoietic organs.
Downloads
Downloads
Published
Issue
Section
License
Copyright (c) 2025 BioClinix: Journal of Medical and Pharmaceutical Sciences

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
All articles published in the Journal of Engineering Excellence (JEE) are licensed under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0).
Under this license, authors retain full copyright of their work while granting permission for anyone to read, download, copy, distribute, print, search, or link to the full texts of the articles, or use them for any other lawful purpose, without asking prior permission from the publisher or author — provided that the original work is properly cited.
This open-access license ensures maximum dissemination and impact of the published research by allowing free and immediate access to scholarly work.
For more details, please refer to the official license page:
???? https://creativecommons.org/licenses/by/4.0/
